MENU
SMMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Summit Therapeutics (SMMT) Ownership - Who owns Summit Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 650 460-8308
Employees
105
Web
https://www.smmttx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.51B
P/E Ratio
26.41
Total Cash
486.9M
Projected Growth
N/A
Total Debt
32.5M
Revenue
N/A
Risk (Beta)
-1.90
Dividend Yield
N/A
Total Cash/Share
0.66
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SMMT
Capitalization
12.5B
P/E Ratio
26.41
Risk (Beta)
-1.90
Dividend Yield
N/A
Total Cash
487M
Total Cash/Share
0.66
Total Debt
32.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
438M
P/B Ratio
28.57
Cash Flow
N/A
Earnings
-0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.37M
Current Ratio
8.31
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-183.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-54.53
Shares Held By Institutions
2.06B
Shares Outstanding - Current
737M
Total Liabilities
64.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
611.494
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel medicines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 650 460-8308
Employees
105
Web
https://www.smmttx.com